title: What's preventing us from preventing type 2 diabetes?
authors.affiliation: Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Judith E
authors.initials: JE
authors.lastname: Fradkin
authors.forename: B Tibor
authors.initials: BT
authors.lastname: Roberts
authors.forename: Griffin P
authors.initials: GP
authors.lastname: Rodgers
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D017277:Drug Approval; D018149:Glucose Intolerance / Q000150:complications / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D019458:Insurance Coverage; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000628:therapy*; D056687:Off-Label Use; D050177:Overweight / Q000150:complications / Q000628:therapy; D014481:United States
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin